When is APOE Senioren actually useful?

APOE genotyping (especially for the ε4 allele) is often marketed as a 'senior test,' but its actual utility is limited. For older adults without dementia symptoms or a strong family history, the test provides no clinically actionable information. The ε4 allele increases Alzheimer's risk but is neither necessary nor sufficient for the disease. Since no proven prevention exists, knowing a risk genotype may cause anxiety without leading to concrete medical steps. The test is only useful in specific contexts: clinical trials, familial Alzheimer's disease (e.g., autosomal dominant forms), or when detailed risk counseling is desired. In cardiovascular health, APOE ε4 offers modest risk information, but again, the effect is small. For the general senior population without specific indication, testing is not recommended. Evidence is moderate – association studies exist, but no benefit for individual management has been demonstrated.